Copyright Reports & Markets. All rights reserved.

Global Nivolumab Sales Market Report 2021

Request for Sample of this report
Buy now

1 Nivolumab Market Overview

  • 1.1 Nivolumab Product Scope
  • 1.2 Nivolumab Segment by Type
    • 1.2.1 Global Nivolumab Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Injection 4mL
    • 1.2.3 Injection 10mL
  • 1.3 Nivolumab Segment by Application
    • 1.3.1 Global Nivolumab Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Unresectable Melanoma
    • 1.3.3 Metastatic Melanoma
    • 1.3.4 Metastatic Squamous NSCLC
    • 1.3.5 Classical Hodgkin Lymphoma
    • 1.3.6 Renal Cell Carcinoma
    • 1.3.7 Other
  • 1.4 Nivolumab Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Nivolumab Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Nivolumab Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Nivolumab Price Trends (2016-2027)

2 Nivolumab Estimates and Forecasts by Region

  • 2.1 Global Nivolumab Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Nivolumab Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Nivolumab Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Nivolumab Revenue Market Share by Region (2016-2021)
  • 2.3 Global Nivolumab Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Nivolumab Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Nivolumab Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Nivolumab Estimates and Projections (2016-2027)
    • 2.4.2 Europe Nivolumab Estimates and Projections (2016-2027)
    • 2.4.3 China Nivolumab Estimates and Projections (2016-2027)
    • 2.4.4 Japan Nivolumab Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Nivolumab Estimates and Projections (2016-2027)
    • 2.4.6 India Nivolumab Estimates and Projections (2016-2027)

3 Global Nivolumab Competition Landscape by Players

  • 3.1 Global Top Nivolumab Players by Sales (2016-2021)
  • 3.2 Global Top Nivolumab Players by Revenue (2016-2021)
  • 3.3 Global Nivolumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nivolumab as of 2020)
  • 3.4 Global Nivolumab Average Price by Company (2016-2021)
  • 3.5 Manufacturers Nivolumab Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Nivolumab Market Size by Type

  • 4.1 Global Nivolumab Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Nivolumab Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Nivolumab Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Nivolumab Price by Type (2016-2021)
  • 4.2 Global Nivolumab Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Nivolumab Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Nivolumab Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Nivolumab Price Forecast by Type (2022-2027)

5 Global Nivolumab Market Size by Application

  • 5.1 Global Nivolumab Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Nivolumab Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Nivolumab Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Nivolumab Price by Application (2016-2021)
  • 5.2 Global Nivolumab Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Nivolumab Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Nivolumab Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Nivolumab Price Forecast by Application (2022-2027)

6 North America Nivolumab Market Facts & Figures

  • 6.1 North America Nivolumab Sales by Company
    • 6.1.1 North America Nivolumab Sales by Company (2016-2021)
    • 6.1.2 North America Nivolumab Revenue by Company (2016-2021)
  • 6.2 North America Nivolumab Sales Breakdown by Type
    • 6.2.1 North America Nivolumab Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Nivolumab Sales Breakdown by Type (2022-2027)
  • 6.3 North America Nivolumab Sales Breakdown by Application
    • 6.3.1 North America Nivolumab Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Nivolumab Sales Breakdown by Application (2022-2027)

7 Europe Nivolumab Market Facts & Figures

  • 7.1 Europe Nivolumab Sales by Company
    • 7.1.1 Europe Nivolumab Sales by Company (2016-2021)
    • 7.1.2 Europe Nivolumab Revenue by Company (2016-2021)
  • 7.2 Europe Nivolumab Sales Breakdown by Type
    • 7.2.1 Europe Nivolumab Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Nivolumab Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Nivolumab Sales Breakdown by Application
    • 7.3.1 Europe 133 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 133 Sales Breakdown by Application (2022-2027)

8 China Nivolumab Market Facts & Figures

  • 8.1 China Nivolumab Sales by Company
    • 8.1.1 China Nivolumab Sales by Company (2016-2021)
    • 8.1.2 China Nivolumab Revenue by Company (2016-2021)
  • 8.2 China Nivolumab Sales Breakdown by Type
    • 8.2.1 China Nivolumab Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Nivolumab Sales Breakdown by Type (2022-2027)
  • 8.3 China Nivolumab Sales Breakdown by Application
    • 8.3.1 China 246 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 246 Sales Breakdown by Application (2022-2027)

9 Japan Nivolumab Market Facts & Figures

  • 9.1 Japan Nivolumab Sales by Company
    • 9.1.1 Japan Nivolumab Sales by Company (2016-2021)
    • 9.1.2 Japan Nivolumab Revenue by Company (2016-2021)
  • 9.2 Japan Nivolumab Sales Breakdown by Type
    • 9.2.1 Japan Nivolumab Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Nivolumab Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Nivolumab Sales Breakdown by Application
    • 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Nivolumab Market Facts & Figures

  • 10.1 Southeast Asia Nivolumab Sales by Company
    • 10.1.1 Southeast Asia Nivolumab Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Nivolumab Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Nivolumab Sales Breakdown by Type
    • 10.2.1 Southeast Asia Nivolumab Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Nivolumab Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Nivolumab Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Nivolumab Market Facts & Figures

  • 11.1 India Nivolumab Sales by Company
    • 11.1.1 India Nivolumab Sales by Company (2016-2021)
    • 11.1.2 India Nivolumab Revenue by Company (2016-2021)
  • 11.2 India Nivolumab Sales Breakdown by Type
    • 11.2.1 India Nivolumab Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Nivolumab Sales Breakdown by Type (2022-2027)
  • 11.3 India Nivolumab Sales Breakdown by Application
    • 11.3.1 India Nivolumab Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Nivolumab Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Nivolumab Business

  • 12.1 Ono Pharmaceutical
    • 12.1.1 Ono Pharmaceutical Corporation Information
    • 12.1.2 Ono Pharmaceutical Business Overview
    • 12.1.3 Ono Pharmaceutical Nivolumab Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Ono Pharmaceutical Nivolumab Products Offered
    • 12.1.5 Ono Pharmaceutical Recent Development
  • 12.2 Bristol-Myers Squibb
    • 12.2.1 Bristol-Myers Squibb Corporation Information
    • 12.2.2 Bristol-Myers Squibb Business Overview
    • 12.2.3 Bristol-Myers Squibb Nivolumab Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Bristol-Myers Squibb Nivolumab Products Offered
    • 12.2.5 Bristol-Myers Squibb Recent Development

...

    13 Nivolumab Manufacturing Cost Analysis

    • 13.1 Nivolumab Key Raw Materials Analysis
      • 13.1.1 Key Raw Materials
      • 13.1.2 Key Raw Materials Price Trend
      • 13.1.3 Key Suppliers of Raw Materials
    • 13.2 Proportion of Manufacturing Cost Structure
    • 13.3 Manufacturing Process Analysis of Nivolumab
    • 13.4 Nivolumab Industrial Chain Analysis

    14 Marketing Channel, Distributors and Customers

    • 14.1 Marketing Channel
    • 14.2 Nivolumab Distributors List
    • 14.3 Nivolumab Customers

    15 Market Dynamics

    • 15.1 Nivolumab Market Trends
    • 15.2 Nivolumab Drivers
    • 15.3 Nivolumab Market Challenges
    • 15.4 Nivolumab Market Restraints

    16 Research Findings and Conclusion

      17 Appendix

      • 17.1 Research Methodology
        • 17.1.1 Methodology/Research Approach
        • 17.1.2 Data Source
      • 17.2 Author List

      The global Nivolumab market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nivolumab market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

      Segment by Type
      Injection 4mL
      Injection 10mL

      Segment by Application
      Unresectable Melanoma
      Metastatic Melanoma
      Metastatic Squamous NSCLC
      Classical Hodgkin Lymphoma
      Renal Cell Carcinoma
      Other

      The Nivolumab market is analysed and market size information is provided by regions (countries). Segment by Application, the Nivolumab market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

      By Company
      Ono Pharmaceutical
      Bristol-Myers Squibb

      Buy now